Serological diagnosis of Toxoplasma gondii infection. Recommendations from the French National Reference Center for Toxoplasmosis

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 1, 2016, Pages 22-33

  Villard, O ^a   Cimon, B ^b   L'Ollivier, C ^c   Fricker Hidalgo, H ^d   Godineau, N ^e   Houze, S ^f   Paris, L ^g   Pelloux, H ^d   Villena, I ^h   Candolfi, E ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL MICHALLON   (France)

^e Centre Hospitalier de Saint Denis   (France)

^f BICHAT HOSPITAL   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Clinical situations; Recommendations; Serological diagnosis; Toxoplasma; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

AIDS PATIENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; DENMARK; DISEASE SURVEILLANCE; FALSE POSITIVE RESULT; FOLLOW UP; FRANCE; GERMANY; GRAFT RECIPIENT; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; ITALY; MATERNAL SCREENING; NONHUMAN; PARASITE TRANSMISSION; PERINATAL PERIOD; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SERODIAGNOSIS; TOXOPLASMOSIS; VERTICAL TRANSMISSION; BLOOD; PROCEDURES; SEROLOGY;

ANTIBODIES, PROTOZOAN; FRANCE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SEROLOGIC TESTS; TOXOPLASMOSIS;

EID: 84949321853     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.09.009     Document Type: Article

References (83)

1. Ajzenberg D., Cogne N., Paris L., Bessieres M.H., Thulliez P., Filisetti D., et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002, 186:684-689.
2. Ajzenberg D., Yera H., Marty P., Paris L., Dalle F., Menotti J., et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis 2009, 199:1155-1167.
3. Ambroise-Thomas P., Schweitzer M., Pinon J.M., Thiebaugeorges O. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med 2001, 185:665-683. [discussion 684-8].
4. Arevalo J.F., Belfort R., Muccioli C., Espinoza J.V. Ocular toxoplasmosis in the developing world. Int Ophthalmol Clin 2010, 50:57-69.
5. Ashburn D., Chatterton J.M., Evans R., Joss A.W., Ho-Yen D.O. Success in the toxoplasma dye test. J Infect 2001, 42:16-19.
6. Aubert D., Foudrinier F., Villena I., Pinon J.M., Biava M.F., Renoult E. PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting. J Clin Microbiol 1996, 34:1347.
7. Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 2002, 96(Suppl. 1):S205-S215.
8. Belanger F., Derouin F., Grangeot-Keros L., Meyer L. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups. Clin Infect Dis 1999, 28:575-581.
9. Bellali H., Pelloux H., Villena I., Fricker-Hidalgo H., Le Strat Y., Goulet V. Prevalence of toxoplasmosis in France in 1998: is there a difference between men and women? At what age do children become infected?. Rev Epidemiol Sante Publique 2013, 61:311-317.
10. Bénard A., Petersen E., Salamon R., Chêne G., Gilbert R., Salmi L.R., et al. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 2008, 13(15):1-7.
11. Bessieres M.H., Roques C., Berrebi A., Barre V., Cazaux M., Seguela J.P. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 1992, 45:605-608.
12. Bobic B., Sibalic D., Djurkovic-Djakovic O. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12years after primary toxoplasma infection. Case report. Gynecol Obstet Invest 1991, 31:182-184.
13. Bobic B., Klun I., Vujanic M., Nikolic A., Ivovic V., Zivkovic T., et al. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J Med Microbiol 2009, 58:358-364.
14. Bodaghi B., Cassoux N., Wechsler B., Hannouche D., Fardeau C., Papo T., et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine 2001, 80:263-270.
15. Bories P., Zink E., Mattern J.F., Villard O., Berceanu A., Bilger K., et al. Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT. Bone Marrow Transplant 2012, 47:301-303.
16. Bourdin C., Busse A., Kouamou E., Touafek F., Bodaghi B., Le Hoang P., et al. PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 2014, 52:3987-3991.
17. Bretagne S., Costa J.M., Foulet F., Jabot-Lestang L., Baud-Camus F., Cordonnier C. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis 2000, 2:127-132.
18. Burnett A.J., Shortt S.G., Isaac-Renton J., King A., Werker D., Bowie W.R. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998, 105:1032-1037.
19. Candolfi E., Pastor R., Huber R., Filisetti D., Villard O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis 2007, 58:83-88.
20. Cavattoni I., Ayuk F., Zander A.R., Zabelina T., Bacher A., Cayroglu E., et al. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny. Leuk Lymphoma 2010, 51:1530-1535.
21. Chandrasekar P.H., Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997, 19:685-689.
22. Costa J.M., Pautas C., Ernault P., Foulet F., Cordonnier C., Bretagne S. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000, 38:2929-2932.
23. Dannemann B.R., Vaughan W.C., Thuillez P., Remington J.S. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990, 28:1928-1933.
24. Del Bono V., Canessa A., Bruzzi P., Fiorelli M.A., Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989, 27:2133-2135.
25. Derouin F., Pelloux H., Parasitology ESGoC Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008, 14:1089-1101.
26. Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol 1966, 76:839-851.
27. Desmonts G., Baron A., Offret G., Couvreur J., Lelong M. The local production of antibodies in the course of ocular toxoplasmosis. Arch Ophtalmol Rev Gen Ophtalmol 1960, 20:137-145.
28. Desmonts G., Couvreur J., Thulliez P. Congenital toxoplasmosis. 5 cases of mother-to-child transmission of pre-pregnancy infection. Presse Med 1990, 19:1445-1449.
29. Evans R., Ho-Yen D.O. Evidence-based diagnosis of toxoplasma infection. Eur J Clin Microbiol Infect Dis 2000, 19:829-833.
30. Fekkar A., Ajzenberg D., Bodaghi B., Touafek F., Le Hoang P., Delmas J., et al. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J Clin Microbiol 2011, 49:1513-1517.
31. Fernandez-Sabe N., Cervera C., Farinas M.C., Bodro M., Munoz P., Gurgui M., et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis 2012, 54:355-361.
32. Franck J., Garin Y.J., Dumon H. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 2008, 46:2334-2338.
33. French Food Safety Agency (AFSSA) Toxoplasma gondii: present knowledge and risk assessment of foodborne toxoplasmosis 2005, AFSSA, Maison Alfort.
34. Fricker-Hidalgo H., Brenier-Pinchart M.P., Schaal J.P., Equy V., Bost-Bru C., Pelloux H. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 2007, 26:845-846.
35. Fricker-Hidalgo H., Bulabois C.E., Brenier-Pinchart M.P., Hamidfar R., Garban F., Brion J.P., et al. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 2009, 48:e9-e15.
36. Fricker-Hidalgo H., Cimon B., Chemla C., Darde M.L., Delhaes L., L'Ollivier C., et al. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J Clin Microbiol 2013, 51:2103-2111.
37. Gallino A., Maggiorini M., Kiowski W., Martin X., Wunderli W., Schneider J., et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996, 15:389-393.
38. Garweg J.G., Jacquier P., Boehnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 2000, 38:996-1001.
39. Geissmann F., Derouin F., Marolleau J.P., Gisselbrecht C., Brice P. Disseminated toxoplasmosis following autologous bone marrow transplantation. Clin Infect Dis 1994, 19:800-801.
40. Gilbert R.E., Stanford M.R. Is ocular toxoplasmosis caused by prenatal or postnatal infection?. Br J Ophthalmol 2000, 84:224-226.
41. Gras L., Gilbert R.E., Wallon M., Peyron F., Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004, 132:541-548.
42. Gutierrez J., Rodriguez M., Piedrola G., del Carmen Maroto M. Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis. Clin Microbiol Infect 1997, 3:658-662.
43. Holland G.N. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999, 128:502-505.
44. Holliman R.E., Raymond R., Renton N., Johnson J.D. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994, 112:399-408.
45. Johnson J., Duffy K., New L., Holliman R.E., Chessum B.S., Fleck D.G. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol 1989, 42:536-541.
46. Jost C., Touafek F., Fekkar A., Courtin R., Ribeiro M., Mazier D., et al. Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women. Clin Vaccine Immunol 2011, 18:1908-1912.
47. Kijlstra A., Luyendijk L., Baarsma G.S., Rothova A., Schweitzer C.M., Timmerman Z., et al. Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol 1989, 13:383-386.
48. Lesle F., Touafek F., Fekkar A., Mazier D., Paris L. Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot. Eur J Clin Microbiol Infect Dis 2011, 30:1207-1212.
49. L'Ollivier C., Wallon M., Faucher B., Piarroux R., Peyron F., Franck J. Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol 2012, 19:1326-1328.
50. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
51. Magi B., Migliorini L. Western blotting for the diagnosis of congenital toxoplasmosis. New Microbiol 2011, 34:93-95.
52. Martino R., Bretagne S., Einsele H., Maertens J., Ullmann A.J., Parody R., et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005, 40:67-78.
53. Mets M.B., Holfels E., Boyer K.M., Swisher C.N., Roizen N., Stein L., et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996, 122:309-324.
54. Moncada P.A., Montoya J.G. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti-Infect Ther 2012, 10:815-828.
55. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
56. Montoya J.G., Remington J.S. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 1996, 23:277-282.
57. Montoya J.G., Berry A., Rosso F., Remington J.S. The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. J Clin Microbiol 2007, 45:1463-1468.
58. Morris M.I., Fischer S.A., Ison M.G. Infections transmitted by transplantation. Infect Dis Clin N Am 2010, 24:497-514.
59. Nogareda F., Le Strat Y., Villena I., De Valk H., Goulet V. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation. Epidemiol Infect 2014, 142:1661-1670.
60. Petersen E., Borovio M.V., Guy E., Liesenfeld O., Meroni V., Naessen A., et al. European multicenter sudy of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 2005, 43:1570-1574.
61. Petersen E., Edvinsson B., Lundgren B., Benfield T., Evengard B. Diagnosis of pulmonary infection with Toxoplasma gondii in immunocompromised HIV-positive patients by real-time PCR. Eur J Clin Microbiol Infect Dis 2006, 25:401-404.
62. Pinon J.M., Dumon H., Chemla C., Franck J., Petersen E., Lebech M., et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001, 39:2267-2271.
63. Rabaud C., May T., Lucet J.C., Leport C., Ambroise-Thomas P., Canton P. Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey. Clin Infect Dis 1996, 23:1249-1254.
64. Robert-Gangneux F., Darde M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012, 25:264-296.
65. Robert-Gangneux F., Amrein C., Lavarde V., Botterel F., Dupouy-Camet J. Neosynthesized IgG detected by Western blotting in Toxoplasma-seropositive heart or lung transplant recipients. Transpl Int 2000, 13:448-452.
66. Robert-Gangneux F., Binisti P., Antonetti D., Brezin A., Yera H., Dupouy-Camet J. Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis. Eur J Clin Microbiol Infect Dis 2004, 23:34-38.
67. Robert-Gangneux F., Murat J.B., Fricker-Hidalgo H., Brenier-Pinchart M.P., Gangneux J.P., Pelloux H. The placenta: a main role in congenital toxoplasmosis?. Trends Parasitol 2011, 27:530-536.
68. Rogers N.M., Peh C.A., Faull R., Pannell M., Cooper J., Russ G.R. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transpl Infect Dis 2008, 10:71-74.
69. Sabin A.B., Feldman H.A. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948, 108:660-663.
70. Silveira C., Belfort R., Muccioli C., Abreu M.T., Martins M.C., Victora C., et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001, 131:351-354.
71. Small T.N., Leung L., Stiles J., Kiehn T.E., Malak S.A., O'Reilly R.J., et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000, 25:969-973.
72. Stanford M.R., Tan H.K., Gilbert R.E. Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol 2006, 90:1464-1467.
73. Stillwaggon E., Carrier C.S., Sautter M., McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011, 5:e1333. (1-17).
74. Talabani H., Asseraf M., Yera H., Delair E., Ancelle T., Thulliez P., et al. Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J Clin Microbiol 2009, 47:2131-2135.
75. Tissot Dupont D., Fricker-Hidalgo H., Brenier-Pinchart M.P., Bost-Bru C., Ambroise-Thomas P., Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003, 22:122-125.
76. Turunen H.J., Leinikki P.O., Saari K.M. Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay. J Clin Microbiol 1983, 17:988-992.
77. Villard O., Filisetti D., Roch-Deries F., Garweg J., Flament J., Candolfi E. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol 2003, 41:3537-3541.
78. Villard O., Jung-Etienne J., Cimon B., Franck J., Fricker-Hidalgo H., Godineau N., et al. Le sérodiagnostic de la toxoplasmose en 2010: conduite à tenir et interprétation en fonction des profils sérologiques obtenus par les méthoodes de dépistage. Feuillets Biol 2011, 52:1-7.
79. Villard O., Cimon B., Franck J., Fricker-Hidalgo H., Godineau N., Houze S., et al. Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis. Diagn Microbiol Infect Dis 2012, 73:231-235.
80. Villard O., Breit L., Cimon B., Franck J., Fricker-Hidalgo H., Godineau N., et al. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol 2013, 20:197-204.
81. Villena I., Ancelle T., Delmas C., Garcia P., Brezin A.P., Thulliez P., et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010, 15(25):1-6.
82. Wallon M., Peyron F., Cornu C., Vinault S., Abrahamowicz M., Kopp C.B., et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3years. Clin Infect Dis 2013, 56:1223-1231.
83. Weiss L.M., Dubey J.P. Toxoplasmosis: a history of clinical observations. Int J Parasitol 2009, 39:895-901.